Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
CONMED Corporation

CONMED Corporation (CNMD) Stock Overview

Explore CONMED Corporation’s financial performance, market position, analyst ratings, and future outlook.

CNMD●NYSE
HealthcareMedical - Devices
$49.82
$0.34(0.69%)
U.S. Market opens in 3h 1m

CONMED Corporation (CNMD)

Meyka AI Score

Z

Key Financials

Market Cap1.5B
P/E Ratio26.80
EPS (TTM)$4.55
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$49.94
3 Months$35.22
1 Year Target$27.14

CNMD Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of CONMED Corporation (NYSE: CNMD) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, CONMED Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CNMD on the NYSE shows an RSI of 66.14, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $27.14 for the NYSE listing.

Key metrics behind CONMED Corporation's NYSE-traded stock include a P/E ratio of 26.80 and a market capitalization of 1.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CNMD on the NYSE.

Price Performance (NYSE: CNMD)

1-Day Change
0.59%
5-Day Change
-0.34%
1-Month Change
17.35%
3-Month Change
40.00%
6-Month Change
19.07%
Year-to-Date (YTD) Change
22.59%
1-Year Change
-9.82%
3-Year Change
-56.49%
5-Year Change
-59.69%
All-Time (Max) Change
14573.62%

Contact Information

https://www.conmed.com
727 392 6464
11311 Concept Boulevard, Largo, FL, 33773

Company Facts

39,000 Employees
IPO DateJul 23, 1987
CountryUS
Actively Trading

Frequently Asked Questions